Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Congress Financial Corporation was a prominent asset-based lending (ABL) firm that provided debt financing, revolving credit facilities, and term loans to mid-market companies across various industries, including significant activity in the life sciences, biotechnology, and pharmaceutical sectors. Historically a subsidiary of CoreStates Financial and later First Union/Wachovia (now Wells Fargo), the company played a key role in providing working capital to emerging healthcare firms during the late 1990s and early 2000s. Notable clients in the healthcare space included Impax Laboratories, Zila Pharmaceuticals, and Medisyn Technologies. The company was eventually integrated into the asset-based lending divisions of its parent banks following a series of mergers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Congress Financial.